devinitorg/iati-policy-markers huggingface dataset:
DARP SPV CDH SOFI The proposed investment entails IFCs investment in a special purchase vehicle (DARP SPV) to be set up together with Dinghui Equity Investment Management (Tianjin) Limited Company, and/or its affiliate  (collectively CDH), a leading alternative asset manager in China. The proposed investment will primarily focus on the investment and resolution of non-performing SME portfolios (NPL Portfolios), the investment, greening, and resolution of distressed properties (Single Assets) in China, and the development of distressed asset market in frontier regions of China. Project Outcome: (i) Stakeholder Effects - Capital relief and increasing lending capacity of financial Institutions: The Project is expected to support offloading NPLs from financial institutions with an estimated OPB of US$875 million. This will help financial institutions relieve capital constraints and increase lending capacity. (ii) Stakeholder Effects-Normalization of distressed SME borrowers and distressed property developers. (iii) Environmental effects: Through the Project, IFC will convert the distressed Single Assets into green properties. This will lead to an expected reduction of GHG emission of up to 64,294 t CO2/yr. 

Market Creation (i) Competitiveness: China's distressed asset market is still dominated by state-owned enterprises, with significant developmental gap between Tier-1 cities/coastal provinces and frontier provinces. IFC aims to promote market competition by strengthening the institutional capacity of capable domestic private sector players and to address the market gap by contributing to the improvement of legal infrastructure in frontier provinces and sharing distressed asset resolution experiences with court systems in those markets. (ii) Sustainability: The Project will be IFC's first green distressed asset investment project. IFC aims to promote greater sustainability through standard setting and market enabling by greening distressed Single Assets and promoting international green building standards to the market.
Concord Medical Concord Medical Services Holdings Limited (Concord or the Company), which is listed on the New York Stock Exchange, has 133 centers located in 52 cities across 25 provinces. The Company operates the largest network of radiotherapy and diagnostic imaging centers in China. The Company also acquired a 52% interest in Changan Hospital, a private hospital in Xian, Shaanxi province, in the second quarter of 2012. Over the next three years, Concord will further expand its network by opening 50 new oncology and diagnostic centers, invest in a proton center in Beijing, and invest in an oncology hospital in Guangzhou (together, the Project). 1. Increase access to quality healthcare services. The Project will support an established healthcare service provider to move down-market to frontier provinces, to reach middle- and lower-income households, providing affordable basic radiotherapy services that are not readily available to those populations.  2. Enable knowledge transfer. Successful operation of the Proton Beam, one of the most advanced technologues in radiotherapy, would enable knowledge transfer amongst radiotherapy practitioners both within and outside the Company  3. Demonstration effect. This will be achieved in terms of improving standards and corporate governance in healthcare management, and in sending a positive message to other private sector investors about potential market opportunities in the healthcare sector.  4. Promoting health care reform and the public private partnership model. Concord''s success should help to enhance China''s health authorities'' confidence in private health care providers and increase willingness to further relax the regulatory barriers for private investment in the sector.   5. Create skilled employment opportunities. The Project will provide training and create employment opportunities for a number of specialty healthcare positions, including those of radiologists, which are currently in short supply in China.
China Life Re Company, Limited The project entails an IFC equity investment of up to Rmb130 mn ($16 million approx.) for up to 7.5% of equity in a greenfiled joint stock life reinsurance company, China Life Reinsurance Company Limited (CLRC or the company).  The company will be founded by China Reinsurance (Group) Corporation (China Re) and a number of domestic and foreign investors. The project represents a first major step on the part of China Re, which is 100% government owned, to attract private sector investors into its shareholding.
Alpha Feed Project The Project is to expand the extrusion technology based aquafeed capacity of Shenzhen Alpha Feed Group Company Limited (Alpha, or the Company) in China and Vietnam. The Project will help accelerate the aquaculture industry upgrades, in which IFC will invest up to US$60 million equivalent. (i) Through the Project, the Company will reach and support the growth of about 80,000 additional aqua farmers. Most of them would be switching from other feed providers whose quality of feed or of technical support does not match Alpha's. While all input providers focus on extension work to build customer loyalty, Alpha's differentiating factor is the type of technical support provided that takes a more enterprise level approach focusing more on-farm profitability and sustainability.
(ii) The Project is categorized as climate adaptation. Climate change related higher temperatures increase the risk from eutrophication that impacts water quality. The extruded feed, due to its characteristic of better water stability and consequent lower losses within the water system, reduces such risks. Additionally, better feed conversion ratio (FCR) supports lower impacts on water quality and addresses higher fish metabolism that is related to temperatures.
Shenzhen VTB The regulatory framework for microfinance in China is still evolving.  China Banking Regulatory Commission (CBRC) has developed the Village Township Bank (VTB) concept, which supports the establishment of microfinance institutions (MFIs) with a full banking license, including deposit taking authority, primarily in rural areas and usually limited to a single county.  IFC has invested in two VTBs, both in the frontier regions.  Today, there are around 100 VTBs in China.  CBRC wants now to move the VTB concept one step further by creating around 1,300 new VTBs in the next three years.  In this context, six VTB licenses are to be granted in Shenzhen, the first Special Economic Zone established in the early 80s to pilot new economic structures.  The granting of the licenses is an explicit effort by CBRC and the Shenzhen government to create momentum for micro, small and medium enterprise (MSME) lending which, despite policy efforts and attempts by state-owned banks in this sector, still seriously lags. Today, Shenzhen generates a GDP of approximately US$114 billion or 2.6% of Chinas overall GDP and 45% of Guangdong Provinces trade.  The basis of this economic powerhouse is MSMEs, which contribute more than 65% of Shenzhens economic output and 87% of its employment.  Yet, only 36% of MSMEs in Shenzhen have access to bank finance, which equates to an estimated unmet demand of several hundred billion RMB.  Moreover, Shenzhens labor force is made up of migrant workers from all over China, especially from frontier regions and rural areas.  A new VTB in Shenzhen specialized in serving MSMEs in effect will support the job creation for migrant workers from poorer regions of the country, as well as enable remittance flows and skill transfer to benefit their less developed home counties and provinces. The new VTB will build on previous investments IFC has made in ZAC to help ZAC become a leading participant in Chinas microfinance sector.  The new VTB will complement ZACs existing operations and may seek to become a regional or nationwide MSME bank when regulations allow for it.  This is important for the microfinance sector in China, where MFIs of nationwide scope have yet to emerge, and since the regulators are looking to VTBs to address many of the challenges currently faced by credit-only MFIs ( MCCs).  

Moreover the new VTB will provide much needed access to finance for MSMEs at a time when China intends to broaden its economic base, encourage domestic demand, and promote the growth of small and medium scale private enterprises.  Funding to MSMEs has proven to create employment and widen entrepreneurship.
DARP Shorevest The proposed project entails IFCs investment in a co-investment vehicle (DARP SPV) to be established with ShoreVest Capital Partners Ltd. (ShoreVest or the Company), an established private asset manager investing in both distressed assets and special situations in China. The DARP SPV will be managed by ShoreVest with an investment period of up to three years. The DARP SPV will focus on investment and resolution of non-performing loan (NPL) portfolios in China, with primary focus on portfolios comprising of SME loans and in frontier regions (the Project). The most significant, expected Project-level outcome is the offloading of US$3 billion in face value of NPLs (both SME and corporate), representing 0.7 percent of the total market for NPL portfolios in China. This will allow FIs to free up their capital and increase liquidity, reduce costs associated with the management of these assets and allow banks to focus on their core lending activities. IFC anticipates that the proposed investment will enhance market competitiveness in the distressed assets market in China by supporting the expansion of a leading private sector distressed asset investor, and the only active foreign investor in a SOE-dominated market.
SINOVATION FUND IV LP Sinovation Fund IV, L.P. (Fund IV or the Fund) is a China-focused early stage technology equity fund. The Fund will invest in companies developing cutting edge technology, product and services in sectors including (a) Artificial Intelligence, (b) E-Commerce, (c) Business-to-Business Services, (d) Education, and (e) Digital Media & Services. The Fund will make its investments mainly to businesses in Greater China, or non-Chinese companies whose product and service can potentially be transferred to Greater China. a.	The Fund will help support the transition of the Chinese economy from a manufacturing to an increasingly innovation and technology driven one by supporting innovation at early stage. The Fund will support the convergence of internet and artificial intelligence with traditional industries such as retail, fintech, logistics/transportation, healthcare, and education.
b.	The Fund is the first in China to create an ecosystem of professional services, co-working space, and mentorship for entrepreneurs; its success and impact have been validated by the number of early stage investments that have raised further funding, with some valued at over US$1 billion today. 
c.	Financial Success: Evidenced by the Manager's past track record and ability to raise successor fund.
Wumart Project Wumart Stores Inc. (Wumart or the company) is one of the leading retail chain store operators in Beijing.  The project is for the company to expand its operations in Beijing and its peripheral areas, as well as improve its technological base and logistics.
Aier Eye Project The proposed project is an expansion of Changsha Aier Eye Hospital Group Co., Ltd (Aier Group or Aier), the largest private eye care network in China.  It currently operates eight full service eye hospitals in different cities.  The project includes expansion and relocation of Wuhan Aier Eye Hospital, Chengdu Aier Eye Hospital, and Hengyang Aier Eye Hospital; construction of Chongqing Aier Eye Hospital, Zhuzhou 331 Aier Eye Hospital, Hefei Aier Eye Hospital, Nanning Aier Eye Hospital, Nanchang Aier Eye Hospital, Shaoyang Aier Eye Hospital, Yueyang Aier Eye Hospital and Haerbin Aier Eye Hospital; and establishment of an optometry school. - Increase access to high quality medical care:   The need for high quality opthalmological care is acute in China, as existing medical resources cannot meet the demand for services. China has less than one-third the number of opthalmologists per capita than the U.S.; and many simple problems, such as myopia, which can be corrected with eyeglasses, go untreated, having implications for education and employment.  Further, most opthalmological hospitals are located in major urban centers, whereas Aier Eye is expanding its operations into second-tier cities, thus serving populations that may not otherwise have access to quality care.    - Demonstrate best practices throughout the medical community:   Aier Eye stresses quality, transparent patient care, and has put in place a system to ensure that it is achieved. For instance, Aier has nearly eliminated the practice of making informal payments to doctorsubiquitous in Chinaby greatly rewarding those doctors who declare such payments and fining those who accept them. The Group has also de-linked doctors remuneration from sales of medications in attempt to combat the common practice of over-prescribing drugs. Aiers focus on staff training and customer service also make it a leader in the country. In April 2006, Aier Eye was cited as the most distinguished and distinctive eye hospital by Health Times, a subsidy of Peoples Daily, the most influential newspaper in China. Further, companies such as Bausch & Lomb, Alcon, and VISX have established Aier Eye as their base for training medical staff on new equipment.  - Establish links with local communities and public entities:  In addition to providing high quality care, Aier establishes links with the local community by carrying out education campaigns, free eye testing in schools, free eye exams in rural areas, and free or discounted surgeries for disadvantaged people. Aier Eye, which began operating within public hospitals, continues to work in conjunction with the public sector, ensuring that they operate in complement to pubic facilities. Aier has training and research relationships with several public universities, including Zhongshan University in South China, Donghua University in East China, and Zhongnan University in Central China, as well as with the Ministry of Health.
APMG Project Asia Pacific Medical Group (APMG or the Company) is a leading medical service provider founded by Michael Choy, a US-trained surgeon, and a group of US-based physicians and surgeons in 1992. APMGs hospitals and clinics offer a range of primary care and specialty services, with focuses including neurology, oncology, cardiovascular, maternity, pediatrics and dermatology. The hospital facilities are located in Beijing, Shanghai and Tianjin. The Company also recently entered a joint venture agreement with a healthcare clinic chain with operations in Singapore, Malaysia and Hong Kong. APMG aims to help Chinese patients to access quality specialty healthcare services. This project is expected to increase access to high quality medical services, promote dissemination of best operational and clinical practices, provide community health services per the China health care reform blueprint, and generate high quality employment opportunity for medical professionals in China.
Ningbo Taihang Agricultural Products Co., Ltd. Summary Of Project Information (SPI)       Project Name    China - Ningbo Agricultural Products Co., Ltd.            Region    Asia        Sector       Project No007229   Projected Board DateJune 15, 1996   Company NameNingbo Agricultural Products Co., Ltd.   Technical Partner and/or Major Shareholders    	1. Tako Co., Ltd. of Japan  2. The Yaohan Group of Japan  3. Kyushu Shiitake Co., Ltd. of Japan  4. IFC    Project Cost Including proposed IFC investment    	US$14 million project cost, with IFC equity participation of US$2 million.    Location of project and Description of site    	The project will construct a shiitake farm in mainly agricultural land located in the Ningbo Economic and Technical Development Zone (NETDC)in Zhejiang province.    Description of Company and Purpose of Project    	The project will construct and operate a spore factory and 250 greenhouses in Zhejiang Province to produce 1,500 tons per annum of natural log shiitake mushrooms.  The Company will be the first in China to grow and harvest natural log shiitake mushrooms mainly for export to Japan, the major consumer of this product.  Japanese production of the natural log shiitake has been in decline recently due to high labor and raw material costs, while increasing consumption has been supplemented by a lower grade substitute grown on a sawdust substrate. The project will contribute to Chinas economic growth by providing a minimum of 200 jobs at full capacity and generating about US$10 million each year in export revenues. IFC has advised the Company on an adequate financial structure and strongly recommended a phased project implementation approach. IFCs participation would be crucial to the equity participation of other sponsors.     Environmental Category and Issues    	This project is rated as a Category B according to IFC environmental guidelines.  Environmental issues include liquid effluent, solid waste and sourcing of wood supply.  Occupational health and safety issues include general workplace safety.      The  is available from the Public Information Center.       Date SPI sent to PIC     May 10, 1996      For Additional Information contact:  Corporate Relations Unit -   telephone: (202) 473-7711   facsimile: (202) 676-0365  Environmental documents for this project are available at http://www.ifc.org and from the World Bank InfoShop (http://www.worldbank.org/html/pic/aboutinfo.html).
Shanghai Aerospace Computer System Engineering Co., Ltd Shanghai Aerospace Computer System Engineering Co., Ltd (SAC or the company) is a private shareholding company, engaging in the development of a multi-media medical training system, an image processing and satellite transmission system, and distance learning platform.  SAC provides a satellite platform for, and partners with, the medical universities & colleges in China and other public partners to provide long distance medical education and training to working medical staff to upgrade their medical education level and fulfill their continuing education requirements.    The proposed project is an expansion of the SACs existing distance medical education and training services to working healthcare professionals throughout China.  The project includes expansion of SACs satellite network, helping local partners (medical schools and hospitals) set up additional distance learning centers and continuing medical education only learning centers, setting up additional data technical support centers, and design and production of educational programs and software.
China Cube Water Loan Initially established in 2006, China Cube Water Limited (CCW or the Company) is a municipal wastewater treatment (WWT) company. CCW, as a private end-to-end WWT operator in China, now has 9 operating WWT assets with a capacity of 207,500 tons per day (tpd) across 4 provinces as of December 31, 2020. It also has a pipeline with 105,000 tpd additional capacity under development from 4 expansion projects. IFC proposes a 10-year loan of RMB420 million (~US$64 million) to CCW, including an IFC A loan of up to RMB210 million and parallel loan of RMB210 million from at least one other development finance institution (DFI), to support the Companys maintenance, upgrade and expansion, and repayment of existing project level debt Assessment of Project Outcomes:
IFC anticipates that the project will have positive stakeholder and environment effects through increased access to WWT. The project's focus on frontier regions will increase access in areas where treatment rates are lower than in China's large urban areas. Moreover, water pollution control remains a pressing issue in China where WWT plays a pivotal role by reducing the release of pollutants and the contamination of local water sources caused by the discharge of untreated water. The project will support expansion of WWT capacity to satisfy the growing demand of quality water and WWT service. This is expected to have strong positive impact in a province such as Shaanxi that suffers from extreme water stress levels.

Assessment of Contribution to Market Creation:    
The project is expected to contribute to competitiveness in the WWT sector by supporting the expansion of an experienced actor operating in the frontier provinces. The sector remains dominated by SOEs and local SOEs centered on the larger cities, and the project's focus on frontier regions, high operational standards, and subsector initiatives is likely to have a positive demonstration effects for other players to replicate.Â
Birla Carbon PRC The project involves construction of a greenfield carbon black manufacturing facility in the Shandong Province of the Peoples Republic of China by Birla Carbon, a carbon black manufacturing unit of the Aditya Birla Group. The Project is expected to promote environmental best practices by utilizing latest technologies in for emission controls, zero water discharge system and waste heat recovery. It is also expected to create around 140 jobs and improve competitiveness of local tire manufacturing industry.
JD Finance Loan p.cls-NormalWeb {
    margin-top:5pt;
    margin-bottom:5pt;
    text-align:left;
    font-family:'Arial', 'sans-serif';
    font-size:10pt;
    line-height:108%;
    margin-left:0pt;
    margin-right:0pt;
}
span.cls-DefaultParagraphFont {
    font-family:'Arial', 'sans-serif';
    font-size:10pt;
    font-weight:normal;
    margin:0in;
    padding:0in;
}
span.cls-DefaultParagraphFont-000000 {
    font-family:'Arial', 'sans-serif';
    font-size:1pt;
    font-weight:bold;
    margin:0in;
    padding:0in;
}
table { border-collapse:collapse !important; width:100%; table-layout:fixed; border-spacing:0 !important; margin-bottom:15px; } .k-table, .k-table td, table, table td, div table, div table td {outline: 0;border: 1px solid #000;} .k-table td, table td, div table td { padding: 5px;} 
  
  
     
       
          The proposed investment entails a 3-year, up to RMB 300 million (USD 44 million) LCY senior loan to JD Chongqing Microcredit Company (JD CQ MCC), which is the dedicated lending company for the agri-loans under JD Finance. The investment will be secured by the guarantee from its ultimate parent and controller  Beijing JD Financial Technology Holding Co., Ltd. (JD Finance). (i) Expand financial access to the most underserved agricultural MSMEs;
(ii) Promote big data based agri-lending: through introducing the advanced internet and mobile based financial services to agricultural MSMEs, and accumulating the necessary data for framers and MSMEs along the supply chain, the proposed business model could potentially bring revolutionary change to the traditional rural finance service approach and lay a solid ground for the future big data based agri-lending;
(iii) Serve as a pilot program and catalyst to encourage other FIs and ecommerce companies to explore the feasible service model for China rural market.
BioChina Project IFC is considering an equity commitment of up to $5 million to the BioVeda China Fund (the fund or BioChina), an investment vehicle to be established by a select group of institutional investors, to invest in Chinese biotech and life sciences companies.  The Fund will be managed by BioVeda Capital (the manager or BioVeda), a Singapore/US headquartered biotech investment firm which currently manages a $32 million venture fund that has invested in the US and Asia.  The fund is targeting a first closing in early 2005.  BioChina targets to raise up to $25 million to be invested in 3-5 companies to whom the fund would provide both expansion capital and management expertise in order to help to grow their businesses significantly.  Exits are expected to be achieved through a stock exchange listing or a strategic sale.